Anita Boyapati
- Hematology top 2%
- Multiple Myeloma Research and Treatments 16
- Acute Myeloid Leukemia Research 9
- Autoimmune and Inflammatory Disorders Research 6
- Oncology top 10%
- Peptidase Inhibition and Analysis 6
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 6
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies 9
- Genetics top 10%
-
- Monoclonal and Polyclonal Antibodies Research 11
-
- COVID-19 Clinical Research Studies 5
- Co-authors
- Dong‐Er ZhangLuke F. PetersonMing YanKathleen RundellEiki KanbeJérôme MsihidYang WangCheryl L. Willman
- Cited by
- HematologyOncologyMolecular Biology
- Partner nations
- United StatesFranceBelgium
In The Last Decade
Anita Boyapati
52 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 80
- Hematology 611
- Oncology 347
- Molecular Biology 719
- Rheumatology 137
- Genetics 87
Countries citing papers authored by Anita Boyapati
This map shows the geographic impact of Anita Boyapati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Boyapati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Boyapati more than expected).
Fields of papers citing papers by Anita Boyapati
This network shows the impact of papers produced by Anita Boyapati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Boyapati. The network helps show where Anita Boyapati may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anita Boyapati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 37 | |
| 6 | 2022 | 9 | |
| 7 | 2021 | 27 | |
| 8 | 2021 | 8 | |
| 9 | 2020 | 32 | |
| 10 | 2020 | 29 | |
| 11 | 2019 | 31 | |
| 12 | 2016 | 41 | |
| 13 | 2011 | 102 | |
| 14 | 2011 | 6 | |
| 15 | 2010 | 34 | |
| 16 | 2007 | 8 | |
| 17 | 2006 | 203 | |
| 18 | 2003 | 22 | |
| 19 | 2003 | 9 | |
| 20 | 2001 | 100 |
About Anita Boyapati
Anita Boyapati is a scholar working on Hematology, Rheumatology and Oncology, having authored 53 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Acute Myeloid Leukemia Research (9 papers), Rheumatoid Arthritis Research and Therapies (9 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Peptidase Inhibition and Analysis (6 papers), Protein Degradation and Inhibitors (6 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Hematology (611 citations), Oncology (347 citations) and Molecular Biology (719 citations). Anita Boyapati has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Dong‐Er Zhang, Luke F. Peterson, Ming Yan, Kathleen Rundell, Eiki Kanbe, Jérôme Msihid, Yang Wang, Cheryl L. Willman, I‐Ming Chen and Zixing Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.